Blockade of Diabetic Vascular Injury by Controlling of AGE-RAGE System

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|6|4|447-452

ISSN： 1389-4501

Source： Current Drug Targets, Vol.6, Iss.4, 2005-06, pp. : 447-452

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

AGE-RAGE System and Carcinogenesis

By  

Current Pharmaceutical Design, Vol. 14, Iss. 10, 2008-04 ,pp. : 940-945

Bentham Science Publishers

Access to resources Recommend Favorite

Involvement of the Toxic AGEs (TAGE)-RAGE System in the Pathogenesis of Diabetic Vascular Complications: A Novel Therapeutic Strategy

By  

Current Drug Targets, Vol. 11, Iss. 11, 2010-01 ,pp. : 1468-1482

Bentham Science Publishers

Access to resources Recommend Favorite

RAGE: A Novel Target for Drug Intervention in Diabetic Vascular Disease

By Hudson Barry I.   Schmidt Ann Marie  

Pharmaceutical Research, Vol. 21, Iss. 7, 2004-07 ,pp. : 1079-1086

Springer Publishing Company

Access to resources Recommend Favorite

Advanced Glycation End Products (AGEs) and their Receptor (RAGE) System in Diabetic Retinopathy

By  

Current Drug Discovery Technologies, Vol. 3, Iss. 1, 2006-03 ,pp. : 83-88

Bentham Science Publishers

Access to resources Recommend Favorite

Receptor for Advanced Glycation End Products (RAGE): A Novel Therapeutic Target for Diabetic Vascular Complication

By  

Current Pharmaceutical Design, Vol. 14, Iss. 5, 2008-02 ,pp. : 487-495

Bentham Science Publishers

Access to resources Recommend Favorite